The expression of CD163+ macrophages is distributed in released patients with CML-CP (8.73 ± 2.00)%, CML-AP (17.23 ± 3.24)%, and CML-BP groups (34.11 ± 4.95)%, respectively. This evidence concerns the gene CD163 and alkaline phosphatase measurement.